Results 51 to 60 of about 49,583 (189)
Pallidal deep brain stimulation: an effective treatment in Chinese patients with tardive dystonia [PDF]
, 2014 Tardive dystonia is an iatrogenic complication of dopamine receptor antagonist medication such as first-generation antipsychotics. It occurs in up to 2% of patients and only 10% recover after stopping medication.
Peter YM Woo +22 more
core +1 more source
Movement Disorders, Volume 41, Issue 9, Page 2375-2385, September 2026.Abstract Background The posterior subthalamic area (PSA) is a familiarized target for Parkinson's disease (PD) in the lesioning era and has recently been reconsidered for deep brain stimulation (DBS). Objective The aim of this study was to compare the therapeutic efficacy of PSA versus subthalamic nucleus (STN) DBS in tremor‐dominant Parkinson's ...
Zhengyu Lin +7 more
wiley +1 more source
Dopa-responsive dystonia and hyperprolactinaemia : a novel association in two sisters [PDF]
, 2007 Dopa-Responsive Dystonia (DRD) is a rare hereditary condition of childhood-onset dystonia which responds dramatically to treatment with levodopa. It was first described in 1971 as a "hereditary progressive basal ganglia disease with marked diurnal ...
Cachia, Mario J., Galea, Janabel
core
Neuroleptic-Induced Tardive Cervical Dystonia: Clinical Series of 20 Patients [PDF]
, 2009 Background: Cervical dystonia (CD) may be classified according to the underlying cause into primary or secondary CD. Previous exposure to neuroleptics is one of the main Causes of adult-onset secondary dystonia.
Felicio, Andre C. [UNIFESP] +5 more
core +1 more source
Delayed-onset drug-induced movement disorders
Psychiatry and Clinical Psychopharmacology, 2021 Delayed-onset drug-induced movement disorders (tardive syndromes) remain an important clinical problem. There are several phenomenologically and pharmacologically distinct types of tardive syndromes. The term tardive dyskinesia has been used to refer to
Oya Öztürk, Erhan Kurt, Timuçin Oral
doaj
Digital and Biomarker‐Based Monitoring for Schizophrenia‐Treatment Adherence
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.Monitoring technologies integrated with artificial intelligence can enable personalized care, improved adherence, and reduced relapses among psychotic patients. ABSTRACT Background Nonadherence to antipsychotics affects nearly half of patients with schizophrenia, leading to rehospitalization, suicidality, and reduced quality of life.
Samuel Inshutiyimana +5 more
wiley +1 more source
Early Intervention in Psychiatry, Volume 20, Issue 9, September 2026.ABSTRACT Introduction While early intervention services (EIS) have demonstrated short‐term benefits, the long‐term maintenance of these gains remains uncertain. Individuals with first‐episode psychosis exhibit significant variability in their course of recovery.
Olivier Percie du Sert +9 more
wiley +1 more source
Transcranial magnetic stimulation: the road to clinical therapy for dystonia
, 2023 Despite many research studies, transcranial magnetic stimulation (TMS) is not yet an FDA-approved clinical therapy for dystonia patients. This review describes the four major challenges that have historically hindered the clinical translation of TMS. The
Angel V. Peterchev +7 more
core +1 more source
TARDIVE DYSTONIA, TARDIVE DYSKINESIA AND TREATMENT APPROACHES
Psychiatry and Clinical Psychopharmacology, 2021 Antipsychotic drugs, which have been used in psychiatry since 1950’s, do not only have therapeutic effects, but, they also, have some adverse effects.
Cenk Özdemir, Mehmet Eryılmaz
doaj
Dystonia and Parkinson's disease: What is the relationship?
Neurobiology of Disease, 2019 Dystonia and Parkinson's disease are closely linked disorders sharing many pathophysiological overlaps. Dystonia can be seen in 30% or more of the patients suffering with PD and sometimes can precede the overt parkinsonism. The response of early dystonia
Aakash S. Shetty +2 more
doaj +1 more source